Categories: Launch

Ion Exchange inaugurates its new R&D Centre in Patancheru, Telangana

The new facility will further strengthen Ion Exchange India’s Chemicals, Resins and Membranes business in India and globally

Hyderabad, August 09, 2019: Leaders in water and environment management solutions, Ion Exchange (India) Limited, today announces the launch of its new Research & Development Centre at Patancheru in Telangana. The centre will focus on the company’s Chemicals, Resins and Membranes business. It will also provide technical and scientific support to the company’s existing technology and engineering segments for designing new processes and products.

With an investment of around INR 300 million, the R&D Centre will develop new resins, membranes, polymers and speciality chemical technologies related to water, waste water treatment, process separation and purification, speciality process application and catalysis. The microbiology lab within the centre will lay emphasis on enzyme research and application specifically for the textile and food & beverage industry. Many of these products will be import substitutes with very large potential for enhancing the company’s exports.

This state-of-the-art R&D centre is spread over 24,000 sq ft and certified by the Department of Scientific and Industrial Research (DSIR). It includes latest analytical instruments and is manned by a team of highly qualified and experienced researchers.

Speaking during the inauguration of the R&D centre, Mr. Rajesh Sharma, Chairman and Managing Director, Ion Exchange (India) Limited said, “Ion Exchange has been in the forefront of R&D in water and waste water management since 1965. Being pioneers in this industry we have been investing a significant portion of our revenues in research and new technology development thereby maintaining our leadership in markets we serve. Our new R&D centre which is an expansion of our current research and development facility in Hyderabad and Navi Mumbai and will provide an impetus to enhance our competitiveness not only in India but globally. Through our innovations and R&D initiatives we will continue to ‘Make in India’ cutting edge sustainable solutions for industries, institutions, homes and communities”.

With continued innovations, the new R&D centre will offer newer solutions to Ion Exchange customers in India and across geographies it serves.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

5 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

23 hours ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

4 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

5 days ago